Cargando…
The Progress of Induced Pluripotent Stem Cells as Models of Parkinson's Disease
In recent years, induced pluripotent stem cells (iPSCs) were widely used for investigating the mechanisms of Parkinson's disease (PD). Somatic cells from patients with SNCA (α-synuclein), LRRK2 (leucine-rich repeat kinase 2), PINK1 (PTEN induced putative kinase 1), Parkin mutations, and at-risk...
Autores principales: | Kang, Ji-feng, Tang, Bei-sha, Guo, Ji-feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736559/ https://www.ncbi.nlm.nih.gov/pubmed/26880962 http://dx.doi.org/10.1155/2016/4126214 |
Ejemplares similares
-
Induced Pluripotent Stem Cells for Treatment of Alzheimer’s and Parkinson’s Diseases
por: Yefroyev, David A, et al.
Publicado: (2022) -
Modeling Parkinson’s Disease Using Patient-specific Induced Pluripotent Stem Cells
por: Li, Hong, et al.
Publicado: (2018) -
Pluripotent stem cells for Parkinson's disease: progress and challenges
por: Zeng, Xianmin, et al.
Publicado: (2013) -
Parkinson's Disease and Cognitive Impairment
por: Yang, Yang, et al.
Publicado: (2016) -
Using induced pluripotent stem cells for modeling Parkinson’s disease
por: Ke, Minjing, et al.
Publicado: (2019)